Prosecution Insights
Last updated: October 24, 2026
Application No. 19/073,427

ASSIST-AS-NEEDED FUNCTIONAL ELECTRICAL STIMULATION (FES) BASED ON MEASURED USER EFFORT

Non-Final OA §102§103
Filed
Mar 07, 2025
Priority
Mar 08, 2024 — provisional 63/562,903 +1 more
Examiner
BERTRAM, ERIC D
Art Unit
3796
Tech Center
3700 — Mechanical Engineering & Manufacturing
Assignee
Case Western Reserve University
OA Round
1 (Non-Final)
81%
Grant Probability
Favorable
1-2
OA Rounds
1y 6m
Est. Remaining
94%
With Interview

Examiner Intelligence

Grants 81% — above average
81%
Career Allowance Rate
1055 granted / 1298 resolved
+11.3% vs TC avg
Moderate +12% lift
Without
With
+12.4%
Interview Lift
resolved cases with interview
Typical timeline
3y 2m
Avg Prosecution
40 currently pending
Career history
1346
Total Applications
across all art units

Statute-Specific Performance

§101
4.1%
-35.9% vs TC avg
§103
35.9%
-4.1% vs TC avg
§102
29.8%
-10.2% vs TC avg
§112
12.5%
-27.5% vs TC avg
Black line = Tech Center average estimate • Based on career data from 1298 resolved cases

Office Action

§102 §103
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Election/Restrictions Applicant’s election without traverse of Group 1 in the reply filed on 9/21/2026 is acknowledged. Claims 13-22 are withdrawn from further consideration pursuant to 37 CFR 1.142(b) as being drawn to a nonelected Invention, there being no allowable generic or linking claim. Election was made without traverse in the reply filed on 9/21/2026. Information Disclosure Statement The information disclosure statement (IDS) submitted on 3/28/2025 was filed in compliance with the provisions of 37 CFR 1.97. Accordingly, the information disclosure statement is being considered by the examiner. Claim Interpretation Applicant is put on notice that all instances of “and/or” can be treated as “or” such that limitations are optional as only one limitation OR another is required by the claims. Claim Interpretation – 112(f) The following is a quotation of 35 U.S.C. 112(f): (f) Element in Claim for a Combination. – An element in a claim for a combination may be expressed as a means or step for performing a specified function without the recital of structure, material, or acts in support thereof, and such claim shall be construed to cover the corresponding structure, material, or acts described in the specification and equivalents thereof. The following is a quotation of pre-AIA 35 U.S.C. 112, sixth paragraph: An element in a claim for a combination may be expressed as a means or step for performing a specified function without the recital of structure, material, or acts in support thereof, and such claim shall be construed to cover the corresponding structure, material, or acts described in the specification and equivalents thereof. The claims in this application are given their broadest reasonable interpretation using the plain meaning of the claim language in light of the specification as it would be understood by one of ordinary skill in the art. The broadest reasonable interpretation of a claim element (also commonly referred to as a claim limitation) is limited by the description in the specification when 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph, is invoked. As explained in MPEP § 2181, subsection I, claim limitations that meet the following three-prong test will be interpreted under 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph: (A) the claim limitation uses the term “means” or “step” or a term used as a substitute for “means” that is a generic placeholder (also called a nonce term or a non-structural term having no specific structural meaning) for performing the claimed function; (B) the term “means” or “step” or the generic placeholder is modified by functional language, typically, but not always linked by the transition word “for” (e.g., “means for”) or another linking word or phrase, such as “configured to” or “so that”; and (C) the term “means” or “step” or the generic placeholder is not modified by sufficient structure, material, or acts for performing the claimed function. Use of the word “means” (or “step”) in a claim with functional language creates a rebuttable presumption that the claim limitation is to be treated in accordance with 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph. The presumption that the claim limitation is interpreted under 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph, is rebutted when the claim limitation recites sufficient structure, material, or acts to entirely perform the recited function. Absence of the word “means” (or “step”) in a claim creates a rebuttable presumption that the claim limitation is not to be treated in accordance with 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph. The presumption that the claim limitation is not interpreted under 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph, is rebutted when the claim limitation recites function without reciting sufficient structure, material or acts to entirely perform the recited function. Claim limitations in this application that use the word “means” (or “step”) are being interpreted under 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph, except as otherwise indicated in an Office action. Conversely, claim limitations in this application that do not use the word “means” (or “step”) are not being interpreted under 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph, except as otherwise indicated in an Office action. This application includes one or more claim limitations that do not use the word “means,” but are nonetheless being interpreted under 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph, because the claim limitation(s) uses a generic placeholder that is coupled with functional language without reciting sufficient structure to perform the recited function and the generic placeholder is not preceded by a structural modifier. Such claim limitation(s) is/are: “measuring device configured to” in claim 1. Because this/these claim limitation(s) is/are being interpreted under 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph, it/they is/are being interpreted to cover the corresponding structure described in the specification (see structures disclosed in claim 2, for example) as performing the claimed function, and equivalents thereof. If applicant does not intend to have this/these limitation(s) interpreted under 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph, applicant may: (1) amend the claim limitation(s) to avoid it/them being interpreted under 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph (e.g., by reciting sufficient structure to perform the claimed function); or (2) present a sufficient showing that the claim limitation(s) recite(s) sufficient structure to perform the claimed function so as to avoid it/them being interpreted under 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph. Claim Rejections - 35 USC § 102 In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis (i.e., changing from AIA to pre-AIA ) for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status. The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action: A person shall be entitled to a patent unless – (a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale, or otherwise available to the public before the effective filing date of the claimed invention. Claims 1-4, 6-10 and 12 are rejected under 35 U.S.C. 102(a)(1) as being anticipated by Schauer (Applicant-cited NPL: “Sensing motion an muscle activity for feedback control of functional electrical stimulation: Ten years of experience in Berlin”). Regarding claims 1-4, 6 and 12, Schauer discloses a limb muscle rehabilitation system with a controller, a stimulating electrode, and an EMG electrode that, in response to an applied stimulation to a muscle, receives data indicative of muscle movement and determined movement related to volitional muscle force and stimulated muscle force (See section 2.2-2.2.3 and 3.3 and figures 17-19). After the user is instructed to raise their arm, user effort is estimated to correct the expended effort to maximize volitional force while reducing fatigue and achieving a movement goal by altering the stimulation applied, as needed (Section 1.4, 2.4, 3.3 and 4 and figures 17-19). Regarding claim 7, the instructions on how to perform the exercise must be given by some sort of device, including a human speaker, a display, etc. Regarding claims 8-9, stimulation intensity is decreased in order to obtain the desired corrected effort expended by a user which maximizes volitional force relative to stimulated force to reduce slacking. Regarding claim 10, see section 1.3 which discloses modulation of pulse width and/or amplitude. Claim Rejections - 35 USC § 103 In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis (i.e., changing from AIA to pre-AIA ) for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status. The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. The factual inquiries for establishing a background for determining obviousness under 35 U.S.C. 103 are summarized as follows: 1. Determining the scope and contents of the prior art. 2. Ascertaining the differences between the prior art and the claims at issue. 3. Resolving the level of ordinary skill in the pertinent art. 4. Considering objective evidence present in the application indicating obviousness or nonobviousness. This application currently names joint inventors. In considering patentability of the claims the examiner presumes that the subject matter of the various claims was commonly owned as of the effective filing date of the claimed invention(s) absent any evidence to the contrary. Applicant is advised of the obligation under 37 CFR 1.56 to point out the inventor and effective filing dates of each claim that was not commonly owned as of the effective filing date of the later invention in order for the examiner to consider the applicability of 35 U.S.C. 102(b)(2)(C) for any potential 35 U.S.C. 102(a)(2) prior art against the later invention. Claim 5 is rejected under 35 U.S.C. 103 as being obvious over Schauer in view of Xie et al. (Applicant-cited NPL: “Mean frequency derived via Hilber-Huan transform with application to fatigue EMG signal analysis” hereinafter Xie). Schauer discloses the applicant’s basic invention, but is silent as to the fatigue be estimated using median frequency of the data. Xie discloses that the mean frequency of EMG signal can be used to indicate muscle fatigue (see abstract) and the mean and median are conventional spectral variables (see introduction). Therefore, it would have been obvious to one of ordinary skill in the art before the applicant’s effective filing date to modify Schauer to determine fatigue using median frequency as Xie teaches this to be a known methodology in the art. Claim 11 is rejected under 35 U.S.C. 103 as being obvious over Schauer in view of Abraham et al. (US 2026/0054059, hereinafter Abraham). Schauer discloses the applicant’s basic invention, but is silent as to how the stimulation parameters are modulated and activated. Abraham discloses an FES system, and thus is analogous art with Schauer. Abraham discloses that the parameters of FES stimulation can be activated/modulated by using the magnetic fields of a magnet (par. 0015, 0070, 0077). Therefore, it would have been obvious to one of ordinary skill in the art before the applicant’s effective filing date to modify Schauer to utilize a magnet to activate/modulate stimulation as Abraham shows this to be a known methodology in the art that would not have affected to the overall operation or purpose of Schauer. Conclusion The prior art made of record and not relied upon is considered pertinent to applicant's disclosure. See applicant-cited NPL and attached PTO-892, especially: “Contributions to muscle force and EMG by combines neural excitation and electrical stimulation” by Crago et al. “Functional Neuromuscular Stimulation Controlled by Surface Elctromyographic Signals Produced by Volitional Activation of the Same Muscle: Adaptive Removal of the Muscle Response from the Recorded EMG-Signal” by Sennels et al. “M-wave elimination from surface electromyogram of electrically stimulated muscles using singular value decomposition: Preliminary results” by Tabernig et al. “Interaction of post-stroke voluntary effort and functional neuromuscular electrical stimulation” by Makowski et al. “Evaluation of methods for extraction of the volitional EMG in dynamic hybrid muscle activation” by Langzam et al. All of the NPL disclose systems and methods for isolating volitional EMG from stimulated EMG and/or using that information for feedback-controlled stimulation. Any inquiry concerning this communication or earlier communications from the examiner should be directed to Eric D Bertram whose telephone number is (571)272-3446. The examiner can normally be reached Monday-Friday 8am-6pm Central Time. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Jennifer McDonald can be reached at 571-270-3061. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /Eric D. Bertram/Primary Examiner, Art Unit 3796
Read full office action

Prosecution Timeline

Mar 07, 2025
Application Filed
Oct 15, 2026
Non-Final Rejection mailed — §102, §103 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12765961
SYSTEM AND METHOD FOR SURGICAL INSTRUMENT USE PREDICTION
2y 9m to grant Granted Oct 20, 2026
Patent 12758772
MEMS-BASED COCHLEAR IMPLANT
3y 3m to grant Granted Oct 13, 2026
Patent 12752125
EXTERNAL DEFIBRILLATOR WITH LOW VOLTAGE ENERGY STORAGE
2y 12m to grant Granted Oct 06, 2026
Patent 12751728
KIDNEY STONE TREATMENT SYSTEM
2y 3m to grant Granted Oct 06, 2026
Patent 12734366
RELAY-BASED DE-ENERGIZABLE DEFIBRILLATION ASSEMBLY
1y 0m to grant Granted Sep 15, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2
Expected OA Rounds
81%
Grant Probability
94%
With Interview (+12.4%)
3y 2m (~1y 6m remaining)
Median Time to Grant
Low
PTA Risk
Based on 1298 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month